Healthcare utilization and direct medical cost in the years during and after cancer diagnosis in patients with type 2 diabetes mellitus.

ABSTRACT:

Aims/introduction

There is uncertainty about the direct medical costs of type 2 diabetes patients with cancers.

Materials and methods

A population-based retrospective cohort of 99,915 type 2 diabetes patients from the Hong Kong Hospital Authority between 2006 and 2017 was assembled. A total of 16,869 patients who had an initial cancer diagnosis after type 2 diabetes diagnosis were matched with 83,046 patients without cancer (controls) using a matching ratio of up to one-to-five propensity score-matching method. Patients were divided into four categories according to life expectancy. Healthcare service utilization and direct medical costs during the index year, subsequent years and mortality year were compared between patients with and without cancer in each category.

Resu

SUBMITTER: Wu T 

PROVIDER: S-EPMC7610124 | biostudies-literature | 2020 Nov

REPOSITORIES: biostudies-literature